Unlock the full value of your Veeva Platform across every function

Most companies buy Veeva one function at a time. Quality goes first, or Clinical does, and each Vault is scoped and governed by the team that asked for it. A few years in, you own several applications that were each set up well on their own terms, with different naming, different owners, and no plan for how they connect. Veeva ships three releases a year, and they get handled as a technical task because nobody is in a position to decide what the business should do with them.

When a new Vault is scoped, the easiest requirement to write down is "how we do it today." So the old process gets rebuilt, exceptions and all, and every customization becomes something to carry through each release. For a long time that was the accepted approach: the solution follows the business process. Many customers now want the reverse. Veeva's standard processes and best practices are what most of the industry runs on, and staying close to them is what makes a system ready for the AI capabilities arriving next.

Veeva is building AI agents into its applications, and most companies have a pilot or two of their own running somewhere. Whether any of it gets past the pilot depends less on the technology than on the business process underneath: whether the steps are the same from site to site, whether documents are classified the same way in every Vault, whether a product has the same name in quality as it does in regulatory. The closer those processes sit to Veeva's standard, the less there is to fix first.

A sponsor's trial runs through CROs and sites, and a manufacturer's batch runs through contract manufacturers and suppliers. Much of that work still moves by email, spreadsheet, and portal before someone on your side re-enters it into Vault, which is where the delays and the transcription errors come from. The same gap shows up inside the company whenever clinical, regulatory, and quality each hold part of the same record.